United States Ambrisentan Market Report 2016

November 2016 | 111 pages | ID: UA33492A2DBEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ambrisentan

Revenue, means the sales value of Ambrisentan

This report studies sales (consumption) of Ambrisentan in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer HealthCare Pharmaceuticals (Germany)
• GlaxoSmithKline Plc (UK)
• Eli Lilly and Company (US)
• Gilead Sciences, Inc. (US)
• Sanofi S.A (France)
• Nippon Shinyaku Co., Ltd. (Japan)
• United Therapeutics Corp. (US)
• Cipla Limited (India)
• YM BioSciences, Inc. (Canada)
• Actelion Pharmaceuticals Ltd. (Switzerland)
• Arena Pharmaceuticals, Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Ambrisentan in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Ambrisentan Market Report 2016

1 AMBRISENTAN OVERVIEW

1.1 Product Overview and Scope of Ambrisentan
1.2 Classification of Ambrisentan
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Ambrisentan
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Ambrisentan (2011-2021)
  1.4.1 United States Ambrisentan Sales and Growth Rate (2011-2021)
  1.4.2 United States Ambrisentan Revenue and Growth Rate (2011-2021)

2 UNITED STATES AMBRISENTAN COMPETITION BY MANUFACTURERS

2.1 United States Ambrisentan Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Ambrisentan Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Ambrisentan Average Price by Manufactures (2015 and 2016)
2.4 Ambrisentan Market Competitive Situation and Trends
  2.4.1 Ambrisentan Market Concentration Rate
  2.4.2 Ambrisentan Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES AMBRISENTAN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Ambrisentan Sales and Market Share by Type (2011-2016)
3.2 United States Ambrisentan Revenue and Market Share by Type (2011-2016)
3.3 United States Ambrisentan Price by Type (2011-2016)
3.4 United States Ambrisentan Sales Growth Rate by Type (2011-2016)

4 UNITED STATES AMBRISENTAN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Ambrisentan Sales and Market Share by Application (2011-2016)
4.2 United States Ambrisentan Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES AMBRISENTAN MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Ambrisentan Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer HealthCare Pharmaceuticals (Germany)
  5.2.2 Ambrisentan Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer HealthCare Pharmaceuticals (Germany) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc (UK)
  5.3.2 Ambrisentan Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc (UK) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Eli Lilly and Company (US)
  5.4.2 Ambrisentan Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Eli Lilly and Company (US) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Gilead Sciences, Inc. (US)
  5.5.2 Ambrisentan Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Gilead Sciences, Inc. (US) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Sanofi S.A (France)
  5.6.2 Ambrisentan Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Sanofi S.A (France) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Nippon Shinyaku Co., Ltd. (Japan)
  5.7.2 Ambrisentan Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Nippon Shinyaku Co., Ltd. (Japan) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 United Therapeutics Corp. (US)
  5.8.2 Ambrisentan Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 United Therapeutics Corp. (US) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Cipla Limited (India)
  5.9.2 Ambrisentan Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Cipla Limited (India) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 YM BioSciences, Inc. (Canada)
  5.10.2 Ambrisentan Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 YM BioSciences, Inc. (Canada) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Actelion Pharmaceuticals Ltd. (Switzerland)
5.12 Arena Pharmaceuticals, Inc. (US)

6 AMBRISENTAN MANUFACTURING COST ANALYSIS

6.1 Ambrisentan Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Ambrisentan

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Ambrisentan Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Ambrisentan Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES AMBRISENTAN MARKET FORECAST (2016-2021)

10.1 United States Ambrisentan Sales, Revenue Forecast (2016-2021)
10.2 United States Ambrisentan Sales Forecast by Type (2016-2021)
10.3 United States Ambrisentan Sales Forecast by Application (2016-2021)
10.4 Ambrisentan Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ambrisentan
Table Classification of Ambrisentan
Figure United States Sales Market Share of Ambrisentan by Type in 2015
Table Application of Ambrisentan
Figure United States Sales Market Share of Ambrisentan by Application in 2015
Figure United States Ambrisentan Sales and Growth Rate (2011-2021)
Figure United States Ambrisentan Revenue and Growth Rate (2011-2021)
Table United States Ambrisentan Sales of Key Manufacturers (2015 and 2016)
Table United States Ambrisentan Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ambrisentan Sales Share by Manufacturers
Figure 2016 Ambrisentan Sales Share by Manufacturers
Table United States Ambrisentan Revenue by Manufacturers (2015 and 2016)
Table United States Ambrisentan Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Ambrisentan Revenue Share by Manufacturers
Table 2016 United States Ambrisentan Revenue Share by Manufacturers
Table United States Market Ambrisentan Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Ambrisentan Average Price of Key Manufacturers in 2015
Figure Ambrisentan Market Share of Top 3 Manufacturers
Figure Ambrisentan Market Share of Top 5 Manufacturers
Table United States Ambrisentan Sales by Type (2011-2016)
Table United States Ambrisentan Sales Share by Type (2011-2016)
Figure United States Ambrisentan Sales Market Share by Type in 2015
Table United States Ambrisentan Revenue and Market Share by Type (2011-2016)
Table United States Ambrisentan Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ambrisentan by Type (2011-2016)
Table United States Ambrisentan Price by Type (2011-2016)
Figure United States Ambrisentan Sales Growth Rate by Type (2011-2016)
Table United States Ambrisentan Sales by Application (2011-2016)
Table United States Ambrisentan Sales Market Share by Application (2011-2016)
Figure United States Ambrisentan Sales Market Share by Application in 2015
Table United States Ambrisentan Sales Growth Rate by Application (2011-2016)
Figure United States Ambrisentan Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Ambrisentan Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List
Table Bayer HealthCare Pharmaceuticals (Germany) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Ambrisentan Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Ambrisentan Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Ambrisentan Sales Market Share (2011-2016)
Table Gilead Sciences, Inc. (US) Basic Information List
Table Gilead Sciences, Inc. (US) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences, Inc. (US) Ambrisentan Sales Market Share (2011-2016)
Table Sanofi S.A (France) Basic Information List
Table Sanofi S.A (France) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A (France) Ambrisentan Sales Market Share (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Basic Information List
Table Nippon Shinyaku Co., Ltd. (Japan) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Ambrisentan Sales Market Share (2011-2016)
Table United Therapeutics Corp. (US) Basic Information List
Table United Therapeutics Corp. (US) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Therapeutics Corp. (US) Ambrisentan Sales Market Share (2011-2016)
Table Cipla Limited (India) Basic Information List
Table Cipla Limited (India) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Limited (India) Ambrisentan Sales Market Share (2011-2016)
Table YM BioSciences, Inc. (Canada) Basic Information List
Table YM BioSciences, Inc. (Canada) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table YM BioSciences, Inc. (Canada) Ambrisentan Sales Market Share (2011-2016)
Table Actelion Pharmaceuticals Ltd. (Switzerland) Basic Information List
Table Actelion Pharmaceuticals Ltd. (Switzerland) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actelion Pharmaceuticals Ltd. (Switzerland) Ambrisentan Sales Market Share (2011-2016)
Table Arena Pharmaceuticals, Inc. (US) Basic Information List
Table Arena Pharmaceuticals, Inc. (US) Ambrisentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals, Inc. (US) Ambrisentan Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ambrisentan
Figure Manufacturing Process Analysis of Ambrisentan
Figure Ambrisentan Industrial Chain Analysis
Table Raw Materials Sources of Ambrisentan Major Manufacturers in 2015
Table Major Buyers of Ambrisentan
Table Distributors/Traders List
Figure United States Ambrisentan Production and Growth Rate Forecast (2016-2021)
Figure United States Ambrisentan Revenue and Growth Rate Forecast (2016-2021)
Table United States Ambrisentan Production Forecast by Type (2016-2021)
Table United States Ambrisentan Consumption Forecast by Application (2016-2021)